Home Acknowledgement
Article Publicly Available

Acknowledgement

Published/Copyright: December 1, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 12

Published Online: 2007-12-01
Published in Print: 2007-12-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Homocysteine research: alive and kicking!
  2. Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis
  3. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial
  4. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients
  5. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases
  6. Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review
  7. Biomarkers of folate and vitamin B12 status in cerebrospinal fluid
  8. The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review
  9. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review
  10. Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?
  11. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
  12. Hyperhomocysteinemia, DNA methylation and vascular disease
  13. Measuring subclinical atherosclerosis: is homocysteine relevant?
  14. Plasma protein homocysteinylation in uremia
  15. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease
  16. Hyperhomocysteinemia – association with renal transsulfuration and redox signaling in rats
  17. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine
  18. Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias
  19. The molecular basis of homocysteine thiolactone-mediated vascular disease
  20. Importance of folate-homocysteine homeostasis during early embryonic development
  21. Association between homocysteine, vitamin B6 concentrations and inflammation
  22. Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry
  23. Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid
  24. Haptocorrin in humans
  25. Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase
  26. Decreased p66Shc promoter methylation in patients with end-stage renal disease
  27. Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling
  28. Differential expression of γ-aminobutyric acid receptor A (GABAA) and effects of homocysteine
  29. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial
  30. Acknowledgement
  31. Contents, Volume 45, 2007
  32. Author Index
  33. Subject Index
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.511/html
Scroll to top button